Floatz logo

CHOLINE C-11 ION

Cancer of the Prostate

Small moleculeDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Cancer of the Prostate cohort.

Asset / SponsorPhaseRating
Mevrometostat
Pfizer
Phase 3B
i-131-1095
Progenics Pharmaceuticals, Inc.
Phase 2B
17-beta-estradiol
BHR Pharma, LLC
Phase 2CCC
Bhr-200
BHR Pharma, LLC
Phase 2CCC
RETASPIMYCIN
Infinity Pharmaceuticals, Inc.
Phase 2CCC

View all 9 →

Same molecule, other indications

CHOLINE C-11 ION is also rated in:

metastatic prostate carcinomaDormant
B
Indicative ·
57 / 100
View asset →
prostate adenocarcinomaDormant
B
Indicative ·
57 / 100
View asset →
prostate cancerDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →